Clinical research by Zepbound's manufacturer Eli Lilley found that the drug's active ingredient tirzepatide reduces sleep apnea by about 60%.

Lisa Jarvis In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish ...

NBA Hall of Famer Isiah Thomas announced Thursday that he has been diagnosed with Bell’s palsy. “I’ve gotten a lot of love ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.